Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to peribulbar block for glaucoma surgery in morbidly obese adults
IRCT20210118050069N1Phase 2Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of magnesium sulfate in Glaucoma (2 arms), sponsored by Research Institute of Ophthalmology. Primary endpoints: Onset of globe akinesia, Onset of lid akinesia and 1 more. Started Feb 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Glaucoma
Beyond the preview
Go deeper on IRCT20210118050069N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210118050069N1.